Conclusion SGLT2 inhibitors are established therapies for reducing HF outcomes, whereas GLP-1 receptor agonists primarily address cardiometabolic risk with uncertain direct HF benefit
I have energy to workout and Im down 5 lbs since I started using them two months ago
FIGURE 1 2 The mechanism of ferroptosis in diabetes-associated cognitive dysfunction Iron, an essential trace element, crosses the blood-brain barrier via a complex metabolic regulatory network and participates in diverse critical biological processes within the central nervous system, including oxygen transport, energy metabolism, and the synthesis and catabolism of myelin and neurotransmitters (Ursini and Maiorino., 2020)
Cobalamin supplementation contributes to neurological recovery in affected cats, complementing the antiviral suppression of the underlying viral cause
Anti-aging 2
Pre-restart assessment should include: Review of the reason for discontinuation and whether it has been adequately addressed Current weight and glycemic status (if diabetic) Assessment of gastrointestinal symptoms and any contraindications Medication reconciliation to identify potential drug interactions For patients taking insulin or sulfonylureas, consider dose reductions to prevent hypoglycemia For women of childbearing potential using oral contraceptives, recommend backup contraception for 4 weeks after restarting and after each dose increase Discussion of realistic expectations and commitment to continued treatment Patient counseling is essential